Surrogates of immunologic cell death (ICD) and chemoradiotherapy outcomes in head and neck squamous cell carcinoma (HNSCC).doi:10.1016/j.oraloncology.2019.05.019Panagiota EconomopoulouGeorge KoutsodontisAreti StratiEfthymios KirodimosEvangelos Giotakis...
Worldwide, oral and pharyngeal squamous cell carcinoma account for an estimated incidence of about 575 000 tumors and 366 000 tumor deaths every year and, therefore, represent the majority of all head and neck neoplasms [55]. Regarding the entirety of tumor death in the United States, the ...
skin squamous cell carcinomaBackground:The present study aimed to explore the impact of sulforaphane on the growth of sSCC cells, and the activation of miR-199a-5p Methods:Cell viability, count, apoptosis, and invasion assays were performed in the sSCC cell line (SCC-13) in which miR-199a...
Laryngeal Squamous Cell Carcinoma (LSCC) is a squamous cancer with 2.4% new diagnoses each year, accounting for 25% of head and neck cancers, and has a high mortality rate. A deeper understanding of key mechanisms and knowledge of the putative target molecules of theranostic relevance are requir...